Dapagliflozin initiation in chronic heart failure patients improves central sleep apnoea.

Dany Jaffuel Yannick Bouchaut Jean-Pierre Mallet Célia Vidal Nicolas Molinari Arnaud Bourdin Francois Roubille

Published in: ERJ open research (2023)

Dapagliflozin decreases central sleep apnoea in central sleep apnoea patients, thereby sparing the initiation of ventilatory therapy https://bit.ly/41e2fm0.

Keyphrases

ejection fraction
sleep quality
positive airway pressure
physical activity
end stage renal disease
newly diagnosed
prognostic factors
peritoneal dialysis
patient reported outcomes
depressive symptoms